US Food and Drug Administration (USFDA) has completed inspection of FDC’s sterile ophthalmic manufacturing facility located at MIDC Industrial Area at Aurangabad in the state of Maharashtra.
The inspection was carried out in relation to the Ophthalmics products being exported to USA market. The USFDA has made 8 observations for the facility. However, the company continues to export its Ophthalmics products to USA market.
FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: